問題詳情

61.下列何者不可IV bolus給藥,否則會引起嚴重副作用?
(A)paclitaxel
(B)doxorubicin
(C)vincristine
(D)fluorouracil

參考答案

答案:A
難度:困難0.267
書單:沒有書單,新增

用户評論

【用戶】passpass

【年級】高一下

【評論內容】19 下列何項藥品靜脈直接注射(iv bolus),較不易造成嚴重的後果?(A) Calcium gluconate(B) Magnesium sulfate(C) Potassium phosphate(D) Potassium chloride編輯私有筆記及自訂標籤

【用戶】IG:Pharmabook

【年級】高一上

【評論內容】若IV bolus paclitaxel可能因劑量過大造成 neutropenia或不常見的過敏性反應及嚴重的過敏反應其特徵為需要治療之呼吸困難及低血壓、血管性水腫及全身性蕁麻疹。極少數患者即使在化學治療前已接受預防用藥仍然出現致命的反應。接受 TAXOL 的患者於開始輸注 TAXOL 之後,應該繼續接受觀察至少 30 分鐘,此後也要密切觀察。如果發生嚴重的過敏反應,應該立即停止 TAXOL 輸注,並適當的治療過敏性反應。患者以後不可再嘗試使用 TAXOL。輕微的症狀如潮紅、皮膚反應等,無需中止治療TAXOL 應先稀釋過再由靜脈輸注給藥。患者接受TAXOL之前,必須預先給予皮 質類固醇、抗組織胺和H2拮抗劑 (例如dexamethasone、promethazine及 cimetidine 或 ranitidine)Only paclitaxel has been studied on an infusion schedule and the standard bolus schedule is either a three hour or 24-hour infusion. The latter was specifically developed to obviate or ameloriate the potential for anaphylactic or hypersensitivity reactions. The MTD on the 3-hour bolus schedule is 250 mg/m2  repeated at 3-week intervals for a dose intensity of 65-82 mg/m2/ week [61]. Dose limiting toxicity is neutropenia at day 9 to 11 ref:仿單、Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer - PubMed (nih.gov)

【用戶】passpass

【年級】高一下

【評論內容】19 下列何項藥品靜脈直接注射(iv bolus),較不易造成嚴重的後果?(A) Calcium gluconate(B) Magnesium sulfate(C) Potassium phosphate(D) Potassium chloride編輯私有筆記及自訂標籤

【用戶】IG:Pharmabook

【年級】高一上

【評論內容】若IV bolus paclitaxel可能因劑量過大造成 neutropenia或不常見的過敏性反應及嚴重的過敏反應其特徵為需要治療之呼吸困難及低血壓、血管性水腫及全身性蕁麻疹。極少數患者即使在化學治療前已接受預防用藥仍然出現致命的反應。接受 TAXOL 的患者於開始輸注 TAXOL 之後,應該繼續接受觀察至少 30 分鐘,此後也要密切觀察。如果發生嚴重的過敏反應,應該立即停止 TAXOL 輸注,並適當的治療過敏性反應。患者以後不可再嘗試使用 TAXOL。輕微的症狀如潮紅、皮膚反應等,無需中止治療TAXOL 應先稀釋過再由靜脈輸注給藥。患者接受TAXOL之前,必須預先給予皮 質類固醇、抗組織胺和H2拮抗劑 (例如dexamethasone、promethazine及 cimetidine 或 ranitidine)Only paclitaxel has been studied on an infusion schedule and the standard bolus schedule is either a three hour or 24-hour infusion. The latter was specifically developed to obviate or ameloriate the potential for anaphylactic or hypersensitivity reactions. The MTD on the 3-hour bolus schedule is 250 mg/m2  repeated at 3-week intervals for a dose intensity of 65-82 mg/m2/ week [61]. Dose limiting toxicity is neutropenia at day 9 to 11 ref:仿單、Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer - PubMed (nih.gov)